English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

We would like to commend the authors Yu et al. for their study assessing the prevalence of intracranial aneurysms (IAs) in patients with aortopathy. Their review of the literature revealed a 12% prevalence of IAs in patients with aortopathy, leading them to conclude that screening for IA should be considered in patients with aortic disease. One of the studies cited is Kuzmik et al. which reported a 9% prevalence of IA in patients with thoracic aortic aneurysms (TAA), and ran from 1997 to 2009. We recently published the results of a 9-year (2009 to 2018) prospective, follow-up screening study from the same institution, with a much larger sample size. Our study found the prevalence to be much smaller (4.9%), and most of the aneurysms were small in size. The prevalence of IA was also higher in TAAs in the descending aorta (9.09%), compared to the ascending aorta (4.51%), and they are likely caused by different disease processes. While descending TAAs are almost invariably heavily calcified, thrombus containing, and closely related to traditional arteriosclerotic risk factors, ascending TAAs are rarely calcified, almost never contain thrombus, and are genetically mediated. Hypertension, smoking and female gender are known high risk predictors for IA, and it not clear from the study by Yu et al. if these factors increase risk in patients with aortopathy, relative to the population without aortopathy. As regards genetic linkage, the data is heterogeneous. In a mega-analysis of a 1,000 Genomes Project-imputed, genome-wide association study, using data of four previously published aneurysm cohorts, van ‘t Hof et al. found that two established risk loci for IAs and TAAs had nominally significant effects; however, there was no evidence for polygenic overlap. The rationale for screening high-risk populations is based on the 3.2% prevalence found in a standard 50-year-old man without any risk factors as reported in a 2011 meta-analysis. However, recent studies have shown a much higher prevalence due to the increased availability of cross-sectional imaging, with a population-based study showing a prevalence of 7% in adults aged 35 to 75 years. Unruptured intracranial aneurysms (UIA) were found in 11.4% of patients who were imaged for acute stroke in a more recent study. If the prevalence is indeed as high as reported in these studies, it raises serious questions about previous recommendations of screening high risk populations, as their reported higher prevalence was only based on more aggressive screening in selected populations. Screening recommendations should also take into account the possible growth and rupture risk of incidental aneurysms detected on these cross-sectional studies. Most are small aneurysms with low rates of growth and rupture, but they carry significant implications for downstream costs and patient outcomes. There is significant heterogeneity in clinical practice regarding imaging surveillance of UIAs. Frequent imaging surveillance of small, incidentally-detected aneurysms indefinitely using magnetic resonance angiography does not result in better health outcomes, given the costs and complications associated with aneurysm ablation. Computed tomography angiography (CTA) is widely available, cheaper and has high spatial resolution, but it carries concerns of radiation exposure on prolonged surveillance. However, the radiation-induced brain cancer risk is likely low when compared to aneurysm rupture risk, and it does not significantly impact the cost-effectiveness of CTA surveillance of small, incidental aneurysms. There is, Letter to the Editor Regarding “Prevalence of Intracranial Aneurysm in Patients with Aortopathy: A Systematic Review with Meta-Analyses”